Labcorp Holdings financials
$308.81−0.25%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 | Q3 '23 Sep 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.73B | $3.54B | $3.52B | $3.56B | $3.53B | $3.35B | $3.33B | $3.28B | $3.22B | $3.18B | $3.03B | $3.06B |
| Gross profit | $1.11B | $1.01B | $993.2M | $1.03B | $1.05B | $948.0M | $896.3M | $904.4M | $926.4M | $897.3M | $821.4M | $851.2M |
| Gross margin | 29.8% | 28.7% | 28.2% | 28.8% | 29.7% | 28.3% | 26.9% | 27.6% | 28.8% | 28.2% | 27.1% | 27.8% |
| Operating income | $451.6M | $380.8M | $267.6M | $396.6M | $394.5M | $326.0M | $216.5M | $254.1M | $294.8M | $323.8M | -$122.8M | $252.3M |
| Net income | $298.7M | $277.8M | $164.7M | $261.1M | $237.9M | $212.8M | $143.4M | $169.3M | $205.3M | $228.0M | -$167.1M | $183.3M |
| Net margin | 8.0% | 7.9% | 4.7% | 7.3% | 6.7% | 6.4% | 4.3% | 5.2% | 6.4% | 7.2% | −5.5% | 6.0% |
| Diluted EPS | $3.64 | $3.35 | $1.98 | $3.12 | $2.84 | $2.52 | $1.70 | $2.00 | $2.43 | $2.69 | $-1.96 | $2.11 |
| EBITDA | $635.7M | $560.5M | $555.0M | $574.2M | $568.9M | $499.2M | $401.3M | $433.6M | $463.3M | $483.3M | $229.3M | $415.9M |
| Operating cash flow | $445.5M | $191.5M | $614.2M | $387.2M | $620.6M | $18.5M | $777.2M | $277.3M | $561.1M | -$29.8M | $579.6M | $275.5M |
| Free cash flow | $313.9M | $70.5M | $490.3M | $280.5M | $542.7M | -$107.5M | $665.1M | $161.5M | $432.9M | -$163.6M | $412.4M | $170.6M |
| Diluted shares | 82.0M | 82.9M | 83.3M | 83.7M | 83.9M | 84.3M | 84.2M | 84.4M | 84.3M | 84.7M | 85.4M | 87.0M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $141.8M | $981.1M | $532.3M | $598.1M | $647.3M | $369.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $5.92B | $6.40B | $5.65B | $5.65B | $5.65B | $5.64B |
| Total assets | $18.53B | $19.09B | $18.39B | $18.26B | $18.06B | $17.60B |
| Total liabilities | $9.91B | $10.34B | $9.76B | $9.55B | $9.57B | $9.28B |
| Shareholders' equity | $8.62B | $8.75B | $8.64B | $8.71B | $8.49B | $8.32B |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology